MOVING SCIENCE FORWARD
MultiPark is a strategic research area funded by the Swedish Government. Building on the strong tradition of cutting-edge research on Parkinson’s disease at Lund University, our vision is to create new and innovative strategies for improved and novel treatments, disease modifications and eventually cures for neurodegenerative diseases, in order to improve the quality of life for people living and ageing with such disorders.
Parkinson's disease is strongly linked to the degeneration of the brain’s movement center. In the last decade, the question of where the disease begins has led researchers to a different part of the human anatomy. In 2003, the German neuropathologist Heiko Braak presented a theory suggesting that the disease begins in the gut and spreads to the brain. The idea has since, despite vocal critics, gained a lot of ground. Researchers from MultiPark at Lund University now present the first direct evidence that the disease can actually migrate from the gut to the brain.
In the future, people who worry about being affected by Alzheimer's disease could get an answer with the help of a simple test. Such a test could put people at ease who belong to the low risk population, and help those at risk to keep their thinking skills intact as long as possible.
- This is the first study to show that the test works in everyday clinical practice, says MultiPark's Oskar Hansson, associate professor at the Department of Clinical Memory Research at Lund University and senior physician at Skåne University Hospital.
MultiPark's Sara Snogerup Linse was today named this year's recipient of the KTH Royal Institute of Technology’s Great Prize and SEK 1.2 million. The award places her in the same company as Robyn, Hans Rosling och Niklas Zennström.
It is now possible to join the Graduate School on Ageing and Health (SWEAH) for PhD-students from universities that have partnerered with SWEAH. The overarching long-term goal is to develop and strengthen the recruitment base of future leaders in research on ageing and health by creating a sustainable multi- and cross-disciplinary national graduate school for competitive science, which will ultimately lead to improved quality of life, health, medical treatment, and care for our ageing population.
"The societal costs related to dementia diseases are continually climbing, year by year. Meanwhile, only a third of all sufferers are offered a full investigation. Research grants are scarce, and so far not a single person with Alzheimer's disease has been cured. It is time for a change, writes a group of memory researchers together with the Alzheimer Society." - Link to article (in Swedish)